Europe’s Edge: Strong Science, Smart Regulation, and a Predictable Environment for Innovation, Manufacturing, and Market Expansion
June 22, 2026
5B
Type: Breakout Session
Focus Area:
Business Development and Investment
Europe offers a uniquely compelling platform for pharmaceutical growth. World class science, deep talent pools, and leading research infrastructures underpin continuous innovation across the value chain. This strength is reinforced by smart, predictable regulation that balances patient safety with faster pathways for innovation, manufacturing scale up, and market access. Above all, Europe provides a stable geopolitical and regulatory environment—reducing risk, enabling long term planning, and supporting resilient supply chains. With access to a large, integrated market and strong public private collaboration, the EU enables companies to innovate with confidence, manufacture competitively, and expand sustainably. Europe’s edge is not just excellence—it’s predictability, making it a trusted home for investment, innovation, and global pharmaceutical leadership.
Speakers
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}